[Treatment of peptic ulcer in the Zollinger-Ellison syndrome with histamine H2-receptor antagonists (author's transl)]
- PMID: 21785
- DOI: 10.1055/s-0028-1105561
[Treatment of peptic ulcer in the Zollinger-Ellison syndrome with histamine H2-receptor antagonists (author's transl)]
Abstract
Histamine H2-receptor antagonists metiamide and cimetidine were used in the treatment of severe peptic ulceration in Zollinger-Ellison syndrome. The ulcerations were completely healed in all four patients after treatment lasting from six weeks to four-and-a-half-months. Two patients developed recurrent ulcer after the treatment had stopped, but responded to a second course. One patient developed hepatitis B during cimetidine treatment and it is possible that the course of the hepatitis was unfavourable affected by cimetidine. But no other side effects were noted nor was there a significant change in basal serum-gastrin concentration or an increase in H+ secretion. Total gastrectomy remains the treatment of choice in Zollinger-Ellison syndrome, but cimetidine should be considered if the patient refuses operation or operation is not feasible because of a poor general state.
Similar articles
-
H2 receptor antagonists.Am J Hosp Pharm. 1978 Feb;35(2):141-5. Am J Hosp Pharm. 1978. PMID: 24338 Review.
-
Long-term treatment with histamine H2-receptor antagonists in Zollinger-Ellison syndrome.Am J Gastroenterol. 1978 Sep;70(3):286-91. Am J Gastroenterol. 1978. PMID: 717379
-
[Treatment of peptic ulcer with histamine H2 receptor antagonists].Fortschr Med. 1977 Aug 18;95(31):1899-902. Fortschr Med. 1977. PMID: 19347 German.
-
[Cimetidine: a review (author's transl)].Rev Med Chil. 1979 Mar;107(3):245-50. Rev Med Chil. 1979. PMID: 38497 Review. Spanish. No abstract available.
-
Omeprazole in Zollinger-Ellison syndrome. Effects of a single dose and of long-term treatment in patients resistant to histamine H2-receptor antagonists.N Engl J Med. 1984 Mar 22;310(12):758-61. doi: 10.1056/NEJM198403223101205. N Engl J Med. 1984. PMID: 6142418
Cited by
-
Serum gastrin in Zollinger-Ellison syndrome: I. Prospective study of fasting serum gastrin in 309 patients from the National Institutes of Health and comparison with 2229 cases from the literature.Medicine (Baltimore). 2006 Nov;85(6):295-330. doi: 10.1097/01.md.0000236956.74128.76. Medicine (Baltimore). 2006. PMID: 17108778 Free PMC article.
-
[A family with multiple endocrine adenomatosis (MEA Type I) and some additional peculiarities alpha-1-antitrypsin deficiency (twice), polyp of small intestine with heterotopic gastric mucosa (once), medullary thyroid carcinoma (once) (author's transl)].Klin Wochenschr. 1979 May 16;57(10):499-509. doi: 10.1007/BF01487820. Klin Wochenschr. 1979. PMID: 37367 German. No abstract available.
-
Serum gastrin in Zollinger-Ellison syndrome: II. Prospective study of gastrin provocative testing in 293 patients from the National Institutes of Health and comparison with 537 cases from the literature. evaluation of diagnostic criteria, proposal of new criteria, and correlations with clinical and tumoral features.Medicine (Baltimore). 2006 Nov;85(6):331-364. doi: 10.1097/MD.0b013e31802b518c. Medicine (Baltimore). 2006. PMID: 17108779 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources